
Mail Us
Global.CustomerService@glenmarkpharma.com
Call Us
1800 266 6255

Global.CustomerService@glenmarkpharma.com
1800 266 6255
Liraglutide, marketed as Lirafit, is a medication approved for the management of Type 2 Diabetes Mellitus (T2DM). It belongs to a class of drugs known as GLP-1 receptor agonists. GLP-1 stands for “glucagon-like peptide-1,” which is a hormone that helps regulate blood sugar levels.
Liraglutide works by mimicking the effects of GLP-1 in the body. Here's how it helps manage diabetes:
Liraglutide stimulates the release of insulin, which helps lower blood sugar levels after meals.
Liraglutide stimulates the release of insulin, which helps lower blood sugar levels after meals.
Liraglutide slows down the emptying of the stomach, leading to a more gradual rise in blood sugar levels after meals.
Liraglutide offers several benefits in managing Type 2 Diabetes:
Liraglutide helps keep blood sugar levels within target range, reducing the risk of complications.
Many people experience weight loss while using Liraglutide, making it suitable for those who need to shed extra pounds.
Liraglutide has been shown to have cardiovascular benefits, reducing the risk of heart-related problems.
Lirafit is available as an prefilled injectable pen, making it convenient to use.
In the next tab, we’ll discuss how to use Lirafit effectively, including dosage instructions and injection techniques.
DISCLAIMER – The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2022 GLENMARK PHARMACUTICALS LTD – All Rights Reserved | Terms Contitions | Privacy Policy